Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with transformed low grade lymphoma attain durable responses following outpatient radioimmunotherapy with tositumomab and iodine I 131 tositumomab [Bexxar (R)]
    Meeting Abstract

    Zelenetz, A. D.; Saleh, M.; Vose, J.; Younes, A.; Kaminski, M. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Bexxar (R) radioimmunotherapy produces a substantial number of durable complete responses in patents with multiply relapsed or refractory low grade or transformed love grade non-Hodgkin's lymphoma
    Meeting Abstract

    Kaminski, M. S.; Zelenetz, A.; Leonard, J.; Saleh, M.; Jain, V.
    Blood (2002)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • Characteristics of patients with relapsed and refractory low grade non-Hodgkin's lymphoma who sustained durable responses following treatment with tositumomab and iodine I 131 tositumomab (Bexxar (R))
    Meeting Abstract

    Gregory, S. A.; Kaminski, M. S.; Zelenetz, A. D.; Jain, V.
    Blood (2002)

    Fulltext@MSK | Save
  • Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Meeting Abstract

    O'Connor, O. A.; Richon, V.; Moskowitz, C. H.; Zelenetz, A. D.; Macgregor-Cortelli, B.; Curly, T.; Richardson, S.; Tong, W.; Rifkind, R.; Marks, P.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • A phase II, open-label study of CLOFAREX(TM) in pediatric patients with refractory or relapsed acute-myelogenous or lymphoblastic leukemia
    Meeting Abstract

    Jeha, S.; Steinherz, P.; Altman, S.; Rheingold, S.; Gaynon, P.; Goldman, S.; Craig, A.; Weiss, J.; Arceci, R.
    Blood (2002)

    Fulltext@MSK | Save
  • Epoetin alfa treatment improves quality of life and increases hemoglobin levels during chemotherapy for lymphoma, chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) patients with mild-to-moderate anemia
    Meeting Abstract

    Straus, D. J.; Turner, R. R.; Testa, M. A.; Hayes, J. F.; Sarokhan, B. J.
    Blood (2002)

    Fulltext@MSK | Save
  • Long-term in vivo monitoring of the tumor targeted migration of EBV specific cytotoxic T-cells transduced to express HSV-TK by PET scan following repeated in vivo labeling with [I-124]FIAU
    Meeting Abstract

    Doubrovina, E. S.; Doubrovin, M. M.; Ivanova, A.; Ageyeva, L.; Balatoni, J.; Beresten, T.; Finn, R.; Larson, S.; Sadelain, M.; Blasberg, R.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • REL is not the functional target gene within the 2p12-16 amplicon in diffuse large B-cell lymphoma
    Meeting Abstract

    Houldsworth, J.; Olshen, A. B.; Cattoretti, G.; Donnelly, G.; Teruya-Feldstein, J.; Qin, J.; Shen, Y.; Zelenetz, A. D.; Chaganti, R. S. K.
    Blood (2002)

    Fulltext@MSK | Save
  • Cure of lethal beta(0)-thalassemia by lentivirus-mediated globin gene transfer in a novel murine disease model
    Meeting Abstract

    Rivella, S.; May, C.; Chadburn, A.; Riviere, I.; Sadelain, M.
    Blood (2002)

    Fulltext@MSK | Save